{"id":89980,"date":"2026-06-22T19:51:31","date_gmt":"2026-06-22T19:51:31","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/89980\/"},"modified":"2026-06-22T19:51:31","modified_gmt":"2026-06-22T19:51:31","slug":"novartis-to-exit-indian-unit-with-159-million-stake-sale","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/89980\/","title":{"rendered":"Novartis to Exit Indian Unit With $159 Million Stake Sale"},"content":{"rendered":"<p class=\"ArticleBodyText_articleBodyContent__17wqE typography_articleBody___5jDr\" data-component=\"paragraph\"><a href=\"https:\/\/www.bloomberg.com\/quote\/NOVN:SW\" target=\"_blank\" rel=\"noopener nofollow\" class=\"media-ui-Link_link-tVkXhPLPofs-\" data-component=\"link\">Novartis AG<\/a> has agreed to sell a majority stake in its listed Indian unit, marking the culmination of a strategic review announced two years ago.<\/p>\n<p class=\"ArticleBodyText_articleBodyContent__17wqE typography_articleBody___5jDr\" data-component=\"paragraph\">The Swiss drugmaker will sell its 70.68% stake in <a href=\"https:\/\/www.bloomberg.com\/quote\/HCBA:IN\" target=\"_blank\" rel=\"noopener nofollow\" class=\"media-ui-Link_link-tVkXhPLPofs-\" data-component=\"link\">Novartis India Ltd.<\/a> to a consortium of WaveRise Investments, ChrysCapital Fund X and Two Infinity Partners for 14.46 billion rupees ($159 million), according to a <a href=\"https:\/\/www.bloomberg.com\/news\/terminal\/TAPY9LTP3SHS\" class=\"media-ui-Link_link-tVkXhPLPofs- whitespace-normal\" target=\"_blank\" rel=\"noopener nofollow\" data-component=\"link\">statementBloomberg Terminal<\/a> to the exchanges.<\/p>\n","protected":false},"excerpt":{"rendered":"Novartis AG has agreed to sell a majority stake in its listed Indian unit, marking the culmination of&hellip;\n","protected":false},"author":2,"featured_media":89981,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[127],"tags":[4397,197,167,2008,45457,231,1767,36753,206,13223,45456],"class_list":["post-89980","post","type-post","status-publish","format-standard","has-post-thumbnail","category-novartis","tag-drugs","tag-europe","tag-finance","tag-hyderabad","tag-infinity-partners","tag-markets","tag-mergers","tag-mumbai","tag-novartis","tag-novartis-ag-reg","tag-novartis-india-ltd"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116795505881289836","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/89980","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=89980"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/89980\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/89981"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=89980"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=89980"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=89980"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}